Safety and Efficacy of ALZT-OP1a as Adjuvant Treatment in Subjects With Post-Ischemic Stroke Cognitive Impairment (PSCI)


Phase 2 Results N/A

Summary of Purpose

This is a Phase II, randomized, double-blinded, placebo-controlled study for subjects with evidence of PSCI. Trial Stopped: Study halted prematurely prior to initiation but potentially will resume

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 26 June 2017.

1 Jul 2016 26 Jun 2017 1 Aug 2017 1 Nov 2017 1 Jun 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Not available


Not available